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effects other than bleeding and thrombosis (38.5% vs. 16.7%, p= 0.004). Patients on 
TSOAC had a lower [better] mean QoL summary score compared to warfarin treated 
patients (39.2±11.3 vs. 46.8±19.8, p= 0.01). Based on the results of the unadjusted lin-
ear regression model, patients treated with TSOAC had significantly better DASS QoL 
summary score (β = -7.65, 95% CI: -13.49, -1.82, p < 0.05); however, after adjusting for 
differences in patient groups, the effect of TSOAC on QoL became non-significant (β = 
4.47, 95% CI: -5.06, 14.00, p= 0.35) ConClusions: Differences in social-demographic 
characteristics between patients treated with warfarin and TSOAC were observed 
in an inner-city population. After adjusting for patient social-demographic charac-
teristics, TSOAC had no impact on treatment-related QoL.
PCV108
Preliminary VerifiCation of the DiagnostiC aCCuraCy of the 
synDrome Differentiation Questionnaire of Phlegm anD BlooD 
stasis (sDQ-PBs)
Lv M.J.1, Zhang Z.2, Zhang H.Y.2, Chen Z.H.1, Yu C.H.3, Liu G.Y.1, Chen L.J.1, Meng F.L.1, Yang G.L.1
1Liaoning University of Traditional Chinese Medicine, Shenyang, China, 2Affiliated Hospital of 
Liaoning University of Traditional Chinese Medicine, Shenyang, China, 3China Academy of Chinese 
Medical Sciences
objeCtives: SDQ-PBS was a validated and reliable diagnostic instrument 
for syndrome of PBS of angina patients. For well reception and wide applica-
tion, it was important and necessary to verify the diagnostic accuracy of the 
syndrome dimension of the questionnaire before applications. Methods: 
The Fisher’s discriminant model was established for syndrome of PBS dimen-
sion to determine weights of items. Angina patients (40-85 years old) diagnosed 
by coronary angiography or coronary computed tomography were selected to 
complete the SDQ-PBS. Syndrome of PBS and non-PBS (any other syndromes) 
were diagnosed by 3 traditional Chinese medicine physicians. According to the 
Canadian Cardiovascular Society Classification (CCSC), subjects of PBS were 
divided into mild and severe degree. Final scores were calculated combining 
initial scores and weights of items. The diagnostic accuracy was preliminarily 
verified by comparison of final scores and diagnostic threshold. Results: 
The Fisher’s discriminant model = 1.444× somber complexion+1.083× heavy 
body+0.913× purple lips+0.845× poor appetite+0.605× glomus and full-
ness+0.436× sliminess in mouth–6.426. There were 44 subjects (age: 69.12±9.26, 
sex: male,36.36%) involved and 35 were diagnosed PBS, 9 non-PBS. According to 
CCSC, 19 were mild degree and 16 severe. Through the comparison of final scores 
and diagnostic threshold (8.5), 34 of 35 PBS subjects were diagnosed as syndrome 
of PBS, the diagnostic accuracy of the syndrome dimension was 97.143%. Of 9 
non-PBS subjects, 1 was diagnosed PBS, the diagnostic accuracy was 88.889%. For 
subjects of mild and severe degree, 18 and 16 were diagnosed PBS respectively, 
the diagnostic accuracy were 94.737% and 100%. ConClusions: The diagnostic 
accuracy of the syndrome dimension of the questionnaire was high. For different 
degree of angina, the instrument was more suitable for severe patients. In the 
future, more study will be conducted to further verify the diagnostic accuracy of 
the questionnaire.
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objeCtives: To review the quality of economic evaluations of acute stroke imag-
ing to direct thrombolytic therapy and to identify areas for improvement in future 
economic evaluations. Methods: We conducted searches of electronic data-
bases including Medline, EMBASE, CINAHL, Econlit, the NHS Economic Evaluation 
Database and the Tufts Cost-Effectiveness Analysis (CEA) Registry from January 
1950 through July 2012. Inclusion criteria were empirical studies published in any 
language that reported economic evaluation results of two or more imaging inter-
ventions for patients presenting with symptoms suggestive of acute stroke. Study 
quality was assessed by a 35-item checklist published by the British Medical Journal 
(BMJ). Results: A total of 1,063 citations were identified, and 5 met the inclusion 
criteria. Four of 5 papers were explicit in their analysis perspectives, which included 
health care system payers, hospital and other stroke service providers. Two stud-
ies reported results for 5-year time horizons and 3 reported lifetime results. All 
reported morbidity outcomes using the modified Rankin Scale score. The median 
quality score using the BMJ tool was 84.4% (range = 71.9-93.5%). Three studies evalu-
ated perfusion computed tomography (CTP) as a comparator to unenhanced CT 
(UCT) but due to a paucity of data, assumed that CTP outcomes were equivalent 
to those of patients assessed by other imaging modalities. Most studies included 
post-thrombolysis intracranial hemorrhage states but most did not take into con-
sideration the effects of AIS patients who could not tolerate contrast media or who 
incurred contrast-induced nephropathy (CIN). ConClusions: Economic evalua-
tions in acute stroke imaging are of high quality with respect to published methodo-
logical guidelines. Economic analyses of imaging in AIS patients may benefit from 
the inclusion of important clinical components of AIS imaging modeling including 
the incidence of CIN and recurrent stroke in addition to the incorporation of CTP-
specific outcome data.
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objeCtives: To explore the reasons for not initiating or stopping VKA treatment 
in patients with atrial fibrillation (AF) at moderate to high risk of stroke, along 
with the reasons for considering some patients on VKA to be “difficult-to-man-
age”. Methods: A retrospective chart review was conducted with 39 Canadian and 
29 Swedish physicians participating. Three cohorts of AF patients at moderate/high 
stroke risk (CHADS2score ≥ 2 points) were examined: a) VKA naïve, b) had stopped 
VKA treatment or c) receiving VKA and considered “difficult-to-manage”. Variables 
retrieved were: sociodemographic data and comorbidities, variables related with AF 
and its management and the reasons why patients a) never received VKA, b) stopped 
VKA, or c) were considered “difficult-to-manage”. Results: In Canada, 187 patients 
were included (naïve/stopped/difficult-to-manage 62/42/83), 58.3% males, mean (SD) 
age 78.4 (8.9) years. In Sweden, 152 patients were included (naïve/stopped/difficult-
to-manage 39/24/89), 68.4% males, mean (SD) age 76.0 (8.8) years. For VKA naïve 
patients, the most common reasons for not initiating VKAs were: Canada – transient 
nature of AF (40.3%), fall risk (30.6%); Sweden - patient refusal to take VKAs (28.2%), 
fall risk (1.8%), bleeding risk (1.8%). For patients who stopped VKA treatment, the 
most common reasons for discontinuation were: Canada – bleeding event (23.8%), 
patient unable to comply with therapy/monitoring (19.0%); Sweden – bleeding event 
(45.8%), clinical event (18.2%). For patients on VKA the most common reasons for 
being considered “difficult-to-manage” were: Canada – concomitant chronic dis-
eases (55.4%), poor INR control (54.2%); Sweden – difficulties in following dietary/
behaviour advice (24.7%), concomitant chronic diseases (22.5%). ConClusions: In 
Canada and Sweden the reasons for not initiating or stopping VKA treatment in AF 
patients were similar, with fall risk and bleeding events being commonly cited. The 
main reasons for considering a patient on VKA as “difficult-to-manage” are mainly 
related to concomitant diseases in both countries.
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objeCtives: Heart failure leads to significant morbidity and mortality. New phar-
maco-therapeutic interventions based on the patients heart rate have been incor-
porated into treatment algorithms, and may lead to improved clinical outomes. 
We set out to assess the reliability of physiological assessments made at the bed 
side in the abscence of BNP measurements. We also set out to assess adherence 
to new heart failure pharmacotherapeutic algorithm at our hospital, and to iden-
tify the prevalence of atrial fibrilation, and other aetiology in patients presenting 
with heart failure. Methods: Most patients with chronic heart failure are man-
aged in the community by nurse specialist and general practitioners. Patients with 
decompensated acute heart failure usualy present to secondary and tertiary care. 
We undertook an audit to identify all patients presenting with heart failure over a 
10 week period in a London Teaching Hospital (n= 54). Results: The average age 
was 76.6±10.5, there were 30 males, 31 patients were of caucasian descent and 
21 from ethnic minority, 2 patients were not categorised. There was a significant 
decline in heart rate (p= 0.0013), systolic pressure (p= 0.0128) and diastolic pressure 
(p= 0.0254) from admission. Patients with heart failure utilised significantly more 
bed days per admission than other cardiology admissions (10.34±1.3 against other 
cardiolgy- 8.78). Atrial fibrillation was a contributory factor in 16 patients. Ischaemic 
heart disease was noted in 21 patients, valvular heart disease was only noted in 
6 patients. The therapeutic algorithm was not adhered to in most patients. The 
new therapy Ivabradine was under utilised, despite featuring in the algorithm. The 
breakdown of pharmacotherapy on admission: Furosemide (n= 31), beta-blockade 
(n= 26), ACE inhibitors and receptor blockers (n= 26), Aldosterone receptor blockers 
(n= 8), Calcium channel antagonist (n= 9), Nitrates= 10. ConClusions: Physiological 
parameters are useful in guiding therapeutic intervention. The new agents are 
under-utilised, and this may be due to a lack of understanding of their long term 
benefits in saved bed days. Therapies that promote a faster heart rate should be 
utilised with caution.
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objeCtives: To set up a model for effective workplace health management 
as an occupational health service for employees of a steel factory in southern 
Taiwan. Methods: In compliance with the administrative regulation of the com-
pany’s policy, 53 male employees with persistent blood pressure (BP) higher than 
160/100 mmHg, and 23 male employees with persistent fasting blood sugar (FS) 
higher than 200 mg/dl during the last three consecutive annual employee health 
examination were identified through a process of cardiovascular risk assessment, 
and recruited into a health management program, which consisted of health edu-
cation for diet control and regular exercise, mandatory weekly BP or postprandial 
blood sugar (PC) monitoring at company medical office for 3 months, and subject 
was required to submit proof of physician visit and drug treatment if the subject 
was noted to have BP higher than 140/90 mmHg or PC higher than 200 mg/dl in two 
consecutive measurements. Outcome evaluation was analyzed with descriptive 
statistics. Results: At the end of the program, the mean systolic BP among the 53 
hypertensive subjects decreased from 161 mmHg to 145 mmHg, diastolic BP from 
104 mmHg to 94 mmHg, and 7 of them achieved satisfactory BP control under 120/80 
mmHg. The mean PC among the 23 diabetic subjects decreased from 297 mg/dl to 
240 mg/dl, and 5 of them achieved satisfactory PC control under 140mg/dl. Out of 
the 46 subjects who filled out the program satisfaction survey, 97.8% were satisfied 
with the dietary control component of the health education course, 93.5% were 
satisfied with the exercise component, 97.8% were satisfied with weekly BP or PC 
measurements, and 58.7% would recommend the same program to their colleagues 
in the future. ConClusions: Company management policy is a key element in the 
success of workplace health management for the control of chronic diseases with 
high cardiovascular risk such as hypertension and diabetes.
